US 12215090
Agents and methods for treating dysproliferative diseases
granted A61PA61P35/00
Quick answer
US patent 12215090 (Agents and methods for treating dysproliferative diseases) held by Tri-Institutional Therapeutics Discovery Institute, Inc. expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tri-Institutional Therapeutics Discovery Institute, Inc.
- Grant date
- Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61P, A61P35/00